GE liver embolization tool cleared by FDA

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has cleared GE Healthcare’s FlightPlan for Liver advanced imaging tool, which is designed to assist interventionalists plan liver embolization procedures by automatically identifying tumor vicinity vessels.

Using GE’s Innova Vision application, a highlighted 3D roadmap of vessels can be superimposed on the live fluoroscopic image, the company said.

The tool has been commercially available in Europe, Latin America and Asia since 2011.